Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478887 · ClinicalTrials.gov registry record · NA
Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
A NA study of Implementation Science and Cardiovascular Risk, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07478887: Recruiting NA study of Implementation Science and Cardiovascular Risk, sponsored by Johns Hopkins University.
NCT07478887 is a NA study of Implementation Science and Cardiovascular Risk that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,000 participants, below the 1,667-participant average among 13 other Implementation Science trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07478887, a NA study of Implementation Science and Cardiovascular Risk, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective is to evaluate the effectiveness and implementation of the Corrie Lipids Program, a comprehensive digital health initiative designed to address critical gaps in lipid-lowering as a component of ASCVD treatment by delivering an intervention that combines a patient-facing smartphone app, clinician education and coaching, and seamless incorporation into clinical workflows. Researchers plan to assess this multicenter digital health initiative in approximately 1,000 adults with uncontrolled LDL-C and elevated ASCVD risk using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. The study will examine whether the program improves LDL-C goal attainment, app engagement, prescribing patterns, and LDL-C monitoring, while also identifying barriers and facilitators to implementation across sites.
Primary Outcome
LDL-C Goal Achievement assessed 6 months after enrollment in the Corrie Lipids program
Conditions Studied
Interventions
- DEVICE Corrie Lipids Digital Health Program
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07478887 shows while recruiting
NCT07478887 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,667-participant average among 13 other Implementation Science trials with a reported enrollment target (40% lower).
The record links to 5 conditions, with Implementation Science appearing as the primary indexed condition, and to 1 intervention - of which Corrie Lipids Digital Health Program is the first listed.
NCT07478887 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT07478887 about?
NCT07478887 is a clinical study titled "Impact of the Corrie Lipids Digital Health Program on Lipid Optimization". The overall objective is to evaluate the effectiveness and implementation of the Corrie Lipids Program, a comprehensive digital health initiative designed to address critical gaps in lipid-lowering as a component of ASCVD treatment by delivering an intervention that combines a patient-facing smartph...
What is the current status of trial NCT07478887?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-06-20. Estimated completion is 2027-12.
What conditions does trial NCT07478887 study?
This clinical trial studies the following conditions: Implementation Science, Cardiovascular Risk, Digital Health, LDL-C, Lipids.
What interventions are being tested in trial NCT07478887?
The interventions under investigation include: Corrie Lipids Digital Health Program (DEVICE).
Who is sponsoring clinical trial NCT07478887?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07478887 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Implementation Science
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07478887's enrollment target sits among peer trials
1,000 5th of 13 higher than 9 of 13 other Implementation Science trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Implementation Science trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
RECRUITING · NA
-
Deimplementing CXR After CVC (DRAUP) in the ICU
RECRUITING · NA
-
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
RECRUITING · NA
-
Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers
RECRUITING · NA
-
Implementation Pilot of Preoperative CGA Before Major Surgery
RECRUITING · NA
-
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI